Creatine and Creatinine Metabolism - Physiological Reviews

1204 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
WALLIMANN T, AND RÜEGG UT. Creatine supplementation improves
intracellular Ca 2� handling and survival in mdx skeletal
muscle cells. FEBS Lett 439: 357–362, 1998.
791. QUAN A, ADAMS R, EKMARK E, AND BAUM M. Serum creatinine
is a poor marker of glomerular filtration rate in patients with spina
bifida. Dev Med Child Neurol 39: 808–810, 1997.
792. RAMESH V, GUSELLA JF, AND SHIH VE. Molecular pathology of
gyrate atrophy of the choroid and retina due to ornithine aminotransferase
deficiency. Mol Biol Med 8: 81–93, 1991.
793. RAMÍREZ O, CALVA E, AND TREJO A. Creatine regulation in the
embryo and growing chick. Biochem J 119: 757–763, 1970.
794. RAMSEY MJ, NAGAO M, INOUE R, FUJITA H, MATSUSHIMA T,
AND TUCKER JD. Chromosome aberrations induced in mice by
chronic feeding of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline
(MeIQ). Food Chem Toxicol 36: 467–474, 1998.
795. RAO JKM, BUJACZ G, AND WLODAWER A. Crystal structure of
rabbit muscle creatine kinase. FEBS Lett 439: 133–137, 1998.
796. RAUCH U, SCHULZE K, WITZENBICHLER B, AND SCHULTHEISS
HP. Alteration of the cytosolic-mitochondrial distribution of highenergy
phosphates during global myocardial ischemia may contribute
to early contractile failure. Circ Res 75: 760–769, 1994.
797. REDDY BS AND RIVENSON A. Inhibitory effect of Bifidobacterium
longum on colon, mammary, and liver carcinogenesis induced
by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.
Cancer Res 53: 3914–3918, 1993.
798. REDONDO DR, DOWLING EA, GRAHAM BL, ALMADA AL, AND
WILLIAMS MH. The effect of oral creatine monohydrate supplementation
on running velocity. Int J Sports Nutr 6: 213–221, 1996.
799. REEVE JL, MCARDLE A, AND JACKSON MJ. Age-related changes
in muscle calcium content in dystrophin-deficient mdx mice. Muscle
Nerve 20: 357–360, 1997.
800. REN J-M AND HOLLOSZY JO. Adaptation of rat skeletal muscle to
creatine depletion: AMP deaminase and AMP deamination. J Appl
Physiol 73: 2713–2716, 1992.
801. REN J-M, OHIRA Y, HOLLOSZY JO, HÄMÄLÄINEN N, TRAUB I,
AND PETTE D. Effects of �-guanidinopropionic acid-feeding on
the patterns of myosin isoforms in rat fast-twitch muscle. Pflügers
Arch 430: 389–393, 1995.
802. REN J-M, SEMENKOVICH CF, AND HOLLOSZY JO. Adaptation of
muscle to creatine depletion: effect on GLUT-4 glucose transporter
expression. Am J Physiol Cell Physiol 264: C146–C150,
1993.
803. REUBER BE, KARL C, REIMANN SA, MIHALIK SJ, AND DODT G.
Cloning and functional expression of a mammalian gene for a
peroxisomal sarcosine oxidase. J Biol Chem 272: 6766–6776,
1997.
804. RICH KJ, ZHAO K, DAVIES DS, BOOBIS AR, AND GOODERHAM
NJ. Developmental changes in hepatic activation of 2-amino-3,8dimethylimidazo[4,5-f]quinoxaline
in rabbit. Carcinogenesis 17:
555–558, 1996.
805. RICHARD I, DEVAUD C, CHERIF D, COHEN D, AND BECKMANN
JS. The gene for creatine kinase, mitochondrial 2 (sarcomeric;
CKMT2), maps to chromosome 5q13.3. Genomics 18: 134–136,
1993.
806. RIKITAKE K, OKA I, ANDO M, YOSHIMOTO T, AND TSURU D.
Creatinine amidohydrolase (creatininase) from Pseudomonas
putida. Purification and some properties. J Biochem 86: 1109–
1117, 1979.
807. ROBBANA-BARNAT S, RABACHE M, RIALLAND E, AND FRADIN
J. Heterocyclic amines: occurrence and prevention in cooked
food. Environ Health Perspect 104: 280–288, 1996.
808. ROBERTS JJ AND WALKER JB. Feeding a creatine analog delays
ATP depletion and onset of rigor in ischemic heart. Am J Physiol
Heart Circ Physiol 243: H911–H916, 1982.
809. ROBERTS JJ AND WALKER JB. Higher homolog and N-ethyl analog
of creatine as synthetic phosphagen precursors in brain, heart,
and muscle, repressors of liver amidinotransferase, and substrates
for creatine catabolic enzymes. J Biol Chem 260: 13502–
13508, 1985.
810. ROBERTS JJ AND WALKER JB. Synthesis and accumulation of an
extremely stable high-energy phosphate compound by muscle,
heart, and brain of animals fed the creatine analog, 1-carboxy-
ethyl-2-iminoimidazolidine (homocyclocreatine). Arch Biochem
Biophys 220: 563–571, 1983.
811. ROBIN Y. Biological distribution of guanidines and phosphagens
in marine Annelida and related phyla from California, with a note
on pluriphosphagens. Comp Biochem Physiol 12: 347–367, 1964.
812. ROBISON TW, GIRI SN, AND WILSON DW. Effects of chronic
administration of doxorubicin on myocardial creatine phosphokinase
and antioxidant defenses and levels of lipid peroxidation in
tissues and plasma of rats. J Biochem Toxicol 4: 87–94, 1989.
813. ROCHE J, LACOMBE G, AND GIRARD H. Sur la spécificité de
certaines déguanidases bactériennes génératrices d’urée et sur
l’argininedihydrolase. Biochim Biophys Acta 6: 210–216, 1950.
814. ROCIC B, BREYER D, GRANIC M, AND MILUTINOVIC S. The
effect of guanidino substances from uremic plasma on insulin
binding to erythrocyte receptors in uremia. Horm Metab Res 23:
490–494, 1991.
815. ROENNEBERG T, NAKAMURA H, CRANMER LD, RYAN K, KISHI
Y, AND HASTINGS JW. Gonyauline: a novel endogenous substance
shortening the period of the circadian clock of a unicellular alga.
Experientia 47: 103–106, 1991.
816. ROENNEBERG T, NAKAMURA H, AND HASTINGS JW. Creatine
accelerates the circadian clock in a unicellular alga. Nature 334:
432–434, 1988.
817. ROENNEBERG T AND TAYLOR W. Light-induced phase responses
in Gonyaulax are drastically altered by creatine. J Biol Rhythms
9: 1–12, 1994.
818. ROMAN BB, WIERINGA B, AND KORETSKY AP. Functional equivalence
of creatine kinase isoforms in mouse skeletal muscle.
J Biol Chem 272: 17790–17794, 1997.
819. ROMÃO MJ, TURK D, GOMIS-RÜTH F-X, AND HUBER R. Crystal
structure analysis, refinement and enzymatic reaction mechanism
of N-carbamoylsarcosine amidohydrolase from Arthrobacter sp.
at 20 Å resolution. J Mol Biol 226: 1111–1130, 1992.
820. ROSE WC. The metabolism of creatine and creatinine. Annu Rev
Biochem 2: 187–206, 1933.
821. ROSENSHTRAUKH LV, ANYUKHOVSKY EP, BELOSHAPKO GG,
UNDROVINAS AI, FLEIDERVISH IA, PAJU AY, AND GLUKHOVT-
SEV EV. Some mechanisms of nonspecific antiarrhythmic action
of phosphocreatine in acute myocardial ischemia. Biochem Med
Metab Biol 40: 225–236, 1988.
822. ROSSI A, KAY L, AND SAKS V. Early ischemia-induced alterations
of the outer mitochondrial membrane and the intermembrane
space: a potential cause for altered energy transfer in cardiac
muscle? Mol Cell Biochem 184: 401–408, 1998.
823. ROSSITER HB, CANNELL ER, AND JAKEMAN PM. The effect of
oral creatine supplementation on the 1000-m performance of competitive
rowers. J Sports Sci 14: 175–179, 1996.
824. ROUSLIN W AND BROGE CW. Mechanisms of ATP conservation
during ischemia in slow and fast heart rate hearts. Am J Physiol
Cell Physiol 264: C209–C216, 1993.
825. RUDIN M AND SAUTER A. Dihydropyridine calcium antagonists
reduce the consumption of high-energy phosphates in the rat
brain. A study using combined 31 P/ 1 H magnetic resonance spectroscopy
and 31 P saturation transfer. J Pharmacol Exp Ther 251:
700–706, 1989.
826. RUDNIK-SCHÖNEBORN S, LÜTZENRATH S, BORKOWSKA J,
KARWANSKA A, HAUSMANOWA-PETRUSEWICZ I, AND ZERRES
K. Analysis of creatine kinase activity in 504 patients with proximal
spinal muscular atrophy types I-III from the point of view of
progression and severity. Eur Neurol 39: 154–162, 1998.
827. RUSH JWE, TULLSON PC, AND TERJUNG RL. Molecular and
kinetic alterations of muscle AMP deaminase during chronic creatine
depletion. Am J Physiol Cell Physiol 274: C465–C471, 1998.
828. SADRIEH N, DAVIS CD, AND SNYDERWINE EG. N-acetyltransferase
expression and metabolic activation of the food-derived
heterocyclic amines in the human mammary gland. Cancer Res 56:
2683–2687, 1996.
829. SAHELIAN R AND TUTTLE D. Creatine—Nature’s Muscle
Builder. Garden City Park, NY: Avery, 1997.
830. SAKO EY, KINGSLEY-HICKMAN PB, FROM AHL, FOKER JE, AND
UGURBIL K. ATP synthesis kinetics and mitochondrial function in
the postischemic myocardium as studied by 31 P NMR. J Biol
Chem 263: 10600–10607, 1988.